Exelixis, Inc.EXELNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -9.38% |
| 2024 | -12.80% |
| 2023 | 17.07% |
| 2022 | 28.56% |
| 2021 | 26.62% |
| 2020 | 62.58% |
| 2019 | 84.88% |
| 2018 | 62.48% |
| 2017 | 16.88% |
| 2016 | -0.40% |